Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec 20;8(12):e82945.
doi: 10.1371/journal.pone.0082945. eCollection 2013.

Effects of vascular endothelial growth factor 165 on bone tissue engineering

Lin Feng  1 , Hao Wu  1 , Lingling E  1 , Dongsheng Wang  1 , Fukui Feng  1 , Yuwan Dong  1 , Hongchen Liu  1 , Lili Wang  2
Affiliations

Effects of vascular endothelial growth factor 165 on bone tissue engineering

Lin Feng et al. PLoS One. .

Abstract

To study the relationship between vascular endothelial growth factor (VEGF) and formation and repair of engineering bone, second-generation bone marrow stromal cells (BMSCs) of New Zealand white rabbits that were separated in vitro were transfected with VEGF 165 gene vectors by adenovirus to detect gene expressions. Transfected BMSCs and β-tricalcium phosphate material were complexed and implanted at the femoral injury sites of the study group (n = 12), and the control group (n = 12) were implanted with engineering bones that were not transfected with VEGF. Femoral recoveries of the two groups were observed on the 15th, 30th, 45th and 60th days, and their vascularization and ossification statuses were observed by immunohistochemical methods. The BMSCs transfected with VEGF highly expressed VEGF genes and excreted VEGF. The two groups both experienced increased vascularization and bone volume after implantation (t = 7.92, P<0.05), and the increases of the study group were significantly higher than those of the control group (t = 6.92, P<0.05). VEGF is clinically applicable because it can accelerate the formation and repair of engineering bone by promoting vascularization and ossification.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Design of experimental procedure.
Figure 2
Figure 2. Vascular casting method.
(A) BMSCs, ×200; (B) tricalcium phosphate material; (C) tricalcium phosphate under electron microscope, ×100; (D) tricalcium phosphate under electron microscope, ×40; (E) tricalcium phosphate-complexed BMSCs under electron microscope, ×100; (F) postoperative healing.
Figure 3
Figure 3. VEGF 165 gene expression after transfection.
(A) Positive expression of VEGF in study group (10×10); (B) negative expression of VEGF in control group (10×10).
Figure 4
Figure 4. Relative area ratios of new bones (%).
Figure 5
Figure 5. Ossification results on the 30th, 60th and 90th days (×100).
Left: study group; right: control group. NB: new bone; BM: bone marrow; Arrowheads indicate blood vessels, thick arrows indicate osteoblasts, and thin arrows indicate osteocyte in bone lacuna.
Figure 6
Figure 6. Real-time quantitative PCR and RT-PCR results.
Type I collagen (A) and ALP (B) levels of the BMSCs in the two groups detected on the 14th day using real-time quantitative PCR (n = 6, mean ± SD), *P<0.05; (C) type I collagen, ALP and OCN mRNA levels of the BMSCs in both groups detected on the 14th day using RT-PCR.
Figure 7
Figure 7. Numbers of microvessels at each time point.
Figure 8
Figure 8. Cross sections of undecalcified ground bones 60 days after vascular casting.
Blank arrows indicate cross sections of the blood vessels filled with casting agents. (A) Study group; (B) control group.
Figure 9
Figure 9. CD31 immunohistochemical staining results on the 45th and 90th days.
Upper two: study group; lower two: control group.
See this image and copyright information in PMC

References

    1. Dimuzio P, Tulenko T (2007) Tissue engineering applications to vascular bypass graft development: The use of adipose-derived stem cells. Vasc Surg 45: A99–A103 10.1016/j.jvs.2007.02.046.PubMed:17544030 - DOI - PMC - PubMed
    1. L'Heureux N, Dusserre N, Marini A, Garrido S, de la Fuente L, et al. (2007) Technology insight: the evolution of tissue-engineered vascular grafts-from research to clinical practice. Nat Clin Pract Cardiovasc Med 4: 389–395 10.1038/ncpcardio0930.PubMed:17589429 - DOI - PubMed
    1. Sakai A, Nakamura T, Tsurukami H, Okazaki R, Nishida S, et al. (1996) Bone marrow capacity for bone cells and trabecular bone turnover in immobilized tibia after sciatic neurectomy in mice. Bone 18: 479–86 10.1016/8756-3282(96)00042-7.PubMed:8739907 - DOI - PubMed
    1. Otfinowski J (1993) Heterotopic induction of osteogenesis in the course of neural injury. Patol Pol 44: 133–168. PubMed: 8247639. - PubMed
    1. Hara-Irie F, Amizuka N, Ozawa H (1996) Immunohistochemical and ultrastructural localization of CGRP-positive nerve fibers at the epiphyseal trabecules facing the growth plate of rat femurs. Bone 18: 29–39 10.1016/8756-3282(95)00425-4.PubMed:8717534 - DOI - PubMed

MeSH terms

Substances